EIKN

Eikon Therapeutics, Inc.

A biotech company that watches individual protein molecules move inside living cells to hunt for cancer drugs, running clinical trials for an immunotherapy against melanoma and lung cancer as well as PARP inhibitors for other tumor types. Founded in 2019 by scientists including a Nobel Prize winner, it took its name from the Greek word for "image," a nod to the microscopy that lets it watch proteins in action.